@@ -12,6 +12,18 @@ datasets:
1212 enables prediction of drug response in acute myeloid leukemia. Cell Rep Med.
1313 2024;5(1):101359.
1414 doi : https://doi.org/10.1016/j.xcrm.2023.101359
15+ bladderpdo :
16+ description : Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer
17+ Data includes transcriptomics, mutations, copy number, and drug response data.
18+ references :
19+ - citation : Suk Hyung Lee, Wenhuo Hu, Justin T. Matulay, Mark V. Silva,
20+ Tomasz B. Owczarek, Kwanghee Kim, Chee Wai Chua, LaMont J. Barlow,
21+ Cyriac Kandoth, Alanna B. Williams, Sarah K. Bergren, Eugene J. Pietzak,
22+ Christopher B. Anderson, Mitchell C. Benson, Jonathan A. Coleman, Barry S. Taylor,
23+ Cory Abate‑Shen, James M. McKiernan, Hikmat Al‑Ahmadie, David B. Solit, Michael M. Shen.
24+ Tumor Evolution and Drug Response in Patient‑Derived Organoid Models of Bladder Cancer.
25+ Cell. 2018;173(2):515‑528.e17.
26+ doi : https://doi.org/10.1016/j.cell.2018.03.017
1527 ccle :
1628 description : Cancer Cell Line Encyclopedia (CCLE).
1729 references :
@@ -109,6 +121,24 @@ datasets:
109121 - citation : Shoemaker RH. The NCI60 human tumour cell line anticancer drug screen.
110122 Nat Rev Cancer. 2006;6(10):813-823.
111123 doi : doi:10.1038/nrc1951
124+ pancpdo :
125+ description : Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer
126+ Data includes transcriptomics, mutations, copy number, and drug response data.
127+ references :
128+ - citation : Hervé Tiriac, Pascal Belleau, Dannielle D. Engle, Dennis Plenker, Astrid Deschênes,
129+ Tim D. D. Somerville, Fieke E. M. Froeling, Richard A. Burkhart, Robert E. Denroche, Gun‑Ho Jang,
130+ Koji Miyabayashi, C. Megan Young, Hardik Patel, Michelle Ma, Joseph F. LaComb, Randze L. D. Palmaira,
131+ Ammar A. Javed, Jasmine C. Huynh, Molly Johnson, Kanika Arora, Nicolas Robine, Minita Shah,
132+ Rashesh Sanghvi, Austin B. Goetz, Cinthya Y. Lowder, Laura Martello, Else Driehuis, Nicolas LeComte,
133+ Gokce Askan, Christine A. Iacobuzio‑Donahue, Hans Clevers, Laura D. Wood, Ralph H. Hruban, Elizabeth Thompson,
134+ Andrew J. Aguirre, Brian M. Wolpin, Aaron Sasson, Joseph Kim, Maoxin Wu, Juan C. Bucobo, Peter Allen,
135+ Divyesh V. Sejpal, William Nealon, James D. Sullivan, Jordan M. Winter, Phyllis A. Gimotty, Jean L. Grem,
136+ Dominick J. DiMaio, Jonathan M. Buscaglia, Paul M. Grandgenett, Jonathan R. Brody, Michael A. Hollingsworth,
137+ Grainne M. O’Kane, Faiyaz Notta, Edward Kim, James M. Crawford, Craig Devoe, Allyson Ocean, Christopher L. Wolfgang,
138+ Kenneth H. Yu, Ellen Li, Christopher R. Vakoc, Benjamin Hubert, Sandra E. Fischer, Julie M. Wilson, Richard Moffitt,
139+ Jennifer Knox, Alexander Krasnitz, Steven Gallinger, David A. Tuveson. Organoid Profiling Identifies Common
140+ Responders to Chemotherapy in Pancreatic Cancer. Cancer Discov. 2018;8(9):1112‑1129.
141+ doi : https://doi.org/10.1158/2159-8290.CD-18-0349
112142 prism :
113143 description : Profiling Relative Inhibition Simultaneously in Mixtures
114144 references :
@@ -120,3 +150,17 @@ datasets:
120150 genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell
121151 lines. Nat Biotechnol. 2016;34(4):419-423.
122152 doi : doi:10.1038/nbt.3460
153+ sarcpdo :
154+ description : The landscape of drug sensitivity and resistance in sarcoma
155+ Data includes transcriptomics, mutations, and drug response data.
156+ references :
157+ - citation : Ahmad Al Shihabi, Peyton J. Tebon, Huyen T. L. Nguyen,
158+ Jomjit Chantharasamee, Sara Sartini, Ardalan Davarifar, Alexandra Y. Jensen,
159+ Miranda Diaz‑Infante, Hannah Cox, Alfredo E. Gonzalez, Summer Norris, Jantzen Sperry,
160+ Jonathan Nakashima, Nasrin Tavanaie, Helena Winata, Sorel T. Fitz‑Gibbon,
161+ Takafumi N. Yamaguchi, Jae H. Jeong, Sarah Dry, Arun S. Singh, Bartosz Chmielowski,
162+ Joseph G. Crompton, Anusha K. Kalbasi, Fritz C. Eilber, Francis Hornicek,
163+ Nicholas M. Bernthal, Scott D. Nelson, Paul C. Boutros, Noah C. Federman, Jane Yanagawa,
164+ Alice Soragni. The landscape of drug sensitivity and resistance in sarcoma.
165+ Cell Stem Cell. 2024;31(10):1524‑1542.e4.
166+ doi : https://doi.org/10.1016/j.stem.2024.08.010
0 commit comments